AJR Am J Roentgenol
- LAWRENCE EM
Editorial Comment: Similar Upgrade and Downgrade Rates Between PI-RADS Version
2.0 and Version 2.1.
AJR Am J Roentgenol. 2024;222:e2330325.
BMC Urol
- ZHOU C, Zhang X, Ma H, Zhou Y, et al
USP54 is a potential therapeutic target in castration-resistant prostate cancer.
BMC Urol. 2024;24:32.
- WINDISCH P, Becker I, Tang H, Schroder C, et al
Converting between the International Prostate Symptom Score (IPSS) and the
Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and
external validation.
BMC Urol. 2024;24:28.
Br J Cancer
- O'MALLEY DE, Raspin K, Melton PE, Burdon KP, et al
Acquired copy number variation in prostate tumours: a review of common somatic
copy number alterations, how they are formed and their clinical utility.
Br J Cancer. 2024;130:347-357.
Cancer
- RUAN Y, Heer E, Warkentin MT, Jarada TN, et al
The association between neighborhood-level income and cancer stage at diagnosis
and survival in Alberta.
Cancer. 2024;130:563-575.
Cancer Imaging
- HU C, Qiao X, Hu C, Cao C, et al
The practical clinical role of machine learning models with different algorithms
in predicting prostate cancer local recurrence after radical prostatectomy.
Cancer Imaging. 2024;24:23.
- GUERRA A, Orton MR, Wang H, Konidari M, et al
Clinical application of machine learning models in patients with prostate cancer
before prostatectomy.
Cancer Imaging. 2024;24:24.
Clin Med Insights Oncol
- BENJAMIN DJ, Rezazadeh Kalebasty A
Characterization and Survival Benefit of Drug Approvals for Metastatic Prostate
Cancer, 2004 to 2022.
Clin Med Insights Oncol. 2024;18:11795549241227413.
Eur Radiol
- PADHANI AR, Godtman RA, Schoots IG
Key learning on the promise and limitations of MRI in prostate cancer screening.
Eur Radiol. 2024 Feb 5. doi: 10.1007/s00330-024-10626.
Int J Urol
- HIYAMA Y
Editorial Comment: Proctoscopy following transrectal prostate biopsy can control
rectal bleeding after prostate biopsy.
Int J Urol. 2024;31:143.
J Nucl Med
- KUMAR S, Crumbaker M, Emmett L
Reply: Unraveling the Hypocalcemic Response to (177)Lu-Prostate-Specific Membrane
Antigen Therapy.
J Nucl Med. 2024;65:333-334.
- RAHBAR K, Boegemann M
The Imperative for Comparative Studies in Nuclear Medicine: Elevating
(177)Lu-PSMA-617 in the Treatment Paradigm for mCRPC.
J Nucl Med. 2024 Jan 4:jnumed.123.266952. doi: 10.2967/jnumed.123.266952.
- ASKARI E, Harsini S
Unraveling the Hypocalcemic Response to (177)Lu-Prostate-Specific Membrane
Antigen Therapy.
J Nucl Med. 2024;65:332-333.
J Urol
- MANNAS MP, Deng FM, Ion-Margineanu A, Jones D, et al
Stimulated Raman Histology Interpretation by Artificial Intelligence Provides
Near-Real-Time Pathologic Feedback for Unprocessed Prostate Biopsies.
J Urol. 2024;211:384-391.
- FLORES JM, Vertosick E, Jenkins LC, Cooper J, et al
Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical
Recurrence After Radical Prostatectomy?
J Urol. 2024;211:400-406.
- LOEB S, Sanchez Nolasco T, Byrne N, Allen L, et al
Representation Matters: Trust in Digital Health Information Among Black Patients
With Prostate Cancer.
J Urol. 2024;211:376-383.
PLoS One
- WU H, Wu Y, He P, Liang J, et al
A meta-analysis for the diagnostic accuracy of SelectMDx in prostate cancer.
PLoS One. 2024;19:e0285745.
Prostate
- ULYS A, Jankevicus F, Jievaltas M, Venckus R, et al
Efficacy, tolerability, and safety of teverelix DP in patients with advanced
prostate cancer: A multicenter, open-label, phase 2 trial.
Prostate. 2024 Feb 4. doi: 10.1002/pros.24674.
- HOYOS JA, Londono DR, Hoyos AG, Reyes EC, et al
Impact of presentation timing in metastatic hormone-sensitive prostate cancer:
Characterization of patients and identification of prognostic factors.
Prostate. 2024 Feb 4. doi: 10.1002/pros.24672.
- LUO LS, Huang J, Luan HH, Mubarik S, et al
Estimating disparities of prostate cancer burden and its attributable risk
factors for males across the BRICS-plus, 1990-2019: A comparable study of key
nations with emerging economies.
Prostate. 2024 Feb 8. doi: 10.1002/pros.24673.
Urol Int
- WU S, Feldman AS, Lin SX, Kim MM, et al
Estimated Prostate Volume by Semiautomatic Segmentation of MRI Is More Accurately
Correlated with Radical Prostatectomy Specimen Weight than the Volume Calculated
by Ellipsoid Formula.
Urol Int. 2024;108:35-41.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016